Table 2 Haematological parameters at study inclusion and increase in Hb from baseline until the end of study period.

From: Ferric Carboxymaltose in the treatment of chemotherapy-induced anaemia: an effective, safe and cost- sparing alternative to blood transfusion

Variables

Ferric Carboxymaltose group

Baseline Hb (g/dL)

Mean, SDa

9.2 ± 0.8

Min-Maxa

6.7–10.8

Post-treatment Hbb (g/dL)

Mean, SDa

10.6 ± 1.3

Min-Maxa

7.8–14.2

Δ Hb (g/dL)

Mean, SD

1.37 ± 1.44

Max-Min

(−1.5)–5.3

p value (Baseline vs post-treatment Hb)

<0.0001

Baseline ferritin (ng/mL)

Mean, SDa

255 ± 222

Min-Maxa

4.0–790

Baseline TSAT (%)

Mean, SDa

15.5 ± 9.4

Min-Maxa

3.0–38.4

  1. aAbbreviations: SD – standard deviation; Min – Minimum; Max – Maximum; TSAT – Transferrin saturation.
  2. bHb value at follow-up visit during week 4.
  3. cData were analysed by paired t-test. The significance level was considered p < 0.05.
Back to article page